Cite
HARVARD Citation
Gül, A. et al. (2012). Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study. Annals of the rheumatic diseases. 71 (4), pp. 563-566. [Online].